mesowatch
Home$6.5B J&J Settlement Secures Key Votes Amid Legal Battle
divider

J&J Reportedly Has Enough Votes for $6.5B Settlement of Ovarian Cancer Lawsuits

Court of Law and Justice: Portrait of Beautiful Female Victim Giving Heartfelt Testimony to Judge, Jury. Emotional Speech of Empowered Woman against JNJ for ovarian cancer claims

Bloomberg reported Monday that more than 75% of the plaintiffs who filed lawsuits against Johnson & Johnson claiming that the use of asbestos-contaminated talc products resulted in ovarian cancer have voted in favor of a proposed $6.5 billion settlement

However, the pharmaceutical giant still has a legal hurdle standing in the way of making a third bankruptcy attempt to settle the remaining and future cancer claims against it. 

On July 25 – one day before the deadline for the ovarian cancer claimants to cast their secret votes on J&J’s proposed settlement – an appellate court upheld a bankruptcy court’s ruling from last year denying the company’s second effort to use a subsidiary, LTL Management, to declare Chapter 11 bankruptcy. 

The appellate court ruled that J&J’s potential for future insolvency from payouts to claimants doesn’t justify using a subsidiary to file for bankruptcy. 

J&J plans to appeal the case to the U.S. Supreme Court.

The company has not confirmed that the vote tally for its proposed settlement is finished. J&J earlier set a threshold of more than 75% “yes” votes for filing for bankruptcy for a third time. 

Last month a bipartisan group of U.S. lawmakers proposed federal legislation to prevent companies like J&J from using a subsidiary to file for bankruptcy in the Lone Star State, a maneuver called the “Texas two-step,” to shield themselves from asbestos liability. 

Asbestos in J&J Talc Products

Asbestos was found in J&J’s talc products, including baby powder after an investigation was launched over claims that some consumers who used those products contracted mesothelioma, ovarian cancer, and other cancers. 

In 2020, J&J announced it would stop selling talc-based baby powder in North America and replace it with a cornstarch-based product. However, cancer victims continued to file lawsuits against the company, claiming it knew for decades that some of the talc used in its baby powder contained traces of asbestos. 

J&J agreed to pay a $700 million settlement earlier this year to resolve claims from 42 states and the District of Columbia that the company deceived the public about the safety of its talc products by failing to disclose marketing materials about the danger of asbestos. The company did not admit guilt in settling the claims.

Mary Pieper

Reading Time: 1 mins

Published On: August 12, 2024

Mary Pieper - author

Mary Pieper is a seasoned journalist, focusing on asbestos awareness and legal and medical issues. She earned her Bachelor's in English with a minor in Journalism from the University of Northern Iowa. Mary's extensive experience includes nearly 20 years as a reporter at the Globe Gazette in Mason City, Iowa, demonstrating her commitment to impactful journalism.

More to Read

Section Divider

Amna Anees - November 17, 2024

CHMP Recommends Pembrolizumab and Chemo for Pleural Mesothelioma

Mini Divider
Mesowatch Logo

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy PolicySitemap

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
At Mesowatch, we strive to provide helpful information for your journey. Please remember that the content on our website is for informational purposes only and is protected by copyright law. It is not a substitute for professional medical or legal advice. We encourage you to consult qualified professionals for any health or legal concerns. Disclaimer